New treatments for cancer, rheumatoid arthritis and diabetes are on the horizon thanks to a series private capital deals over the past week.
Alternative investment firms leading the way were: H.I.G. Capital; BlackRock; Surveyor Capital (a Citadel company); New Enterprise Associates; Deerfield Management and Bain Capital Life Sciences.
Below is our weekly run-down of all healthcare-oriented deals $40 million and up for the week ending January 31.
- The deal: $400 million in convertible senior notes.
- The players: Aiming to attract . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.